Check Cap Ltd (NASDAQ:CHEK) shares saw unusually-high trading volume on Friday . Approximately 4,661,692 shares were traded during trading, an increase of 633% from the previous session’s volume of 635,844 shares.The stock last traded at $2.77 and had previously closed at $2.44.

CHEK has been the subject of several recent research reports. Zacks Investment Research upgraded shares of Check Cap from a “hold” rating to a “buy” rating and set a $1.50 target price for the company in a report on Tuesday, June 14th. Maxim Group restated a “buy” rating on shares of Check Cap in a report on Thursday, May 26th. Finally, Chardan Capital reduced their target price on shares of Check Cap from $6.00 to $4.00 and set a “buy” rating for the company in a report on Friday, May 20th.

The firm’s market capitalization is $40.24 million. The company has a 50-day moving average of $1.36 and a 200 day moving average of $2.23.

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.